Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07448129) titled 'Clinical Trial to Evaluate the Efficacy and Safety of SUBMO(R) as a Submucosal Injection Agent in Endoscopic Resection of Superficial Gastrointestinal Lesions' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: i+Med S.Coop.
Condition:
Colorectal Polyps
Intervention:
Device: SUBMO(R) Submucosal Injection
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 2026
Target Sample Size: 300
Countries of Recruitment:
Spain
To know more, visit...